Ignite Creation Date:
2024-05-05 @ 10:54 PM
Last Modification Date:
2024-10-26 @ 10:25 AM
Study NCT ID:
NCT01213641
Status:
COMPLETED
Last Update Posted:
2016-03-28
First Post:
2010-09-30
Brief Title:
Clinical Outcomes and Safety A Registry Study of Ilaris Canakinumab Patients
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neonatal Onset Multisystem Inflam Disease NOMID |
| Cryopyrin-associated Periodic Syndromes CAPS |
| Familial Cold Autoinflam Syn FCAS |
| Muckle-wells Syn MWS |
Keywords:
| Name | View |
|---|---|
| Interleukin-1IL-1 | View |
| Cryopyrin-associated periodic syndromesCAPS | View |
| CIAS1 protein | View |
| NLRP3 protein | View |
| human cryopyrin protein | View |
| Familial Cold Autoinflammatory SyndromeFCAS | View |
| Muckle-Wells SyndromeMWS | View |
| Neonatal Onset Multisystem Inflammatory diseaseNOMID | View |
| NALP3 | View |
| canakinumab | View |